IL1B and epilepsy: For example, interleukin-1beta (IL-1β), one of the most widely studied biomarkers for epileptogenesis, experiences an increased production following traumatic brain injury, thereby amplifying CNS hyperexcitability and excitotoxicity through Ca2+, glutamatergic, and GABAergic mechanisms, potentially culminating in epilepsy [9].